Chapel Hill, NC, United States of America

Mitsuo Yamauchi

This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2014-2019.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsuo Yamauchi: Innovator in Biomatrix Scaffolds

Introduction

Mitsuo Yamauchi is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomaterials, particularly in the development of biomatrix scaffolds. With a total of 2 patents, his work focuses on enhancing tissue engineering and regenerative medicine.

Latest Patents

Yamauchi's latest patents revolve around biomatrix scaffolds. The present invention provides biomatrix scaffolds, a tissue extract enriched for extracellular matrix components and bound growth factors, cytokines, and hormones, along with methods of making and using the same. This innovative approach aims to improve the effectiveness of tissue regeneration.

Career Highlights

Mitsuo Yamauchi is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research and development. His work has garnered attention for its potential applications in medical science and tissue engineering.

Collaborations

Yamauchi collaborates with notable colleagues, including Yunfang Wang and Lola Cynthia McAdams Reid. Their combined expertise contributes to advancing research in biomaterials and regenerative medicine.

Conclusion

Mitsuo Yamauchi's contributions to the field of biomatrix scaffolds highlight his innovative spirit and dedication to improving medical technologies. His work continues to pave the way for advancements in tissue engineering and regenerative medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…